1. Field of the Invention
The present invention relates to containers for carrying and storing medicament automatic injectors before and after use of the injectors. The present invention also relates to a clip for carrying one or more of the containers.
2. Description of Related Art
A medicament automatic injector is a device designed to allow a user to self-administer a pre-measured dose of a medicament composition subcutaneously or intramuscularly, usually in an emergency situation. Automatic injectors are used, for example, to treat anaphylactic (severe allergic) reactions and to administer antidotes for certain poisons, such as chemical nerve agents. One of the most well known automatic injectors is the automatic injector sold under the name EPIPEN® by Meridian Medical Technologies, Inc. (Columbia, Md., United States), which delivers epinephrine.
A typical automatic injector has a housing, inside of which is a cartridge. The cartridge has one or several chambers containing medicament compositions or components thereof and is adapted to be attached to a needle assembly. The automatic injector can house a premixed dosage of medicament, liquid dosages that are mixed prior to injection, or a solid medicament that is dissolved in a liquid transport solution prior to injection. The housing carries an actuation assembly with a stored energy source, for example, a compressed spring. Activation of the actuation assembly causes a sequence of movements, the medicament compound is subsequently forced through the needle and into the user. If the automatic injector is of the type designed to carry several components of the medicament composition in separate, sealed compartments, structure may be included that forces the components to mix when the actuation assembly is activated. When the automatic injector has been used, a needle typically extends from the housing.
Automatic injectors are typically packaged in containers to keep them clean and protect them from damage. However, the typical automatic injector container is not designed to house the automatic injector after use.
One aspect of the invention relates to an automatic injector package. The automatic injector package comprises an automatic injector, a container, and indicia. The automatic injector includes a housing, a cartridge assembly carried within the housing, a needle assembly operatively associated with the cartridge assembly, and an actuation assembly carried by the housing. The actuation assembly includes a stored energy source and a drive assembly driven by the stored energy source. The drive assembly is operatively associated with the cartridge assembly and the needle assembly to expel a medicament from the cartridge and through the needle assembly upon activation of the automatic injector. The container is constructed and arranged to receive the automatic injector before and after use. At least a portion of the container is formed from a light permeable material. The indicia are provided on at least one of the housing and the container and are visible by a user when the automatic injector has been placed into the container after use. The indicia point to an indicating portion that indicates that the automatic injector has been used.
Another aspect of the invention relates to a container for an automatic injector. The container comprises an open end and a closed end opposite the open end. A cap is constructed and arranged to releasably engage the open end so as to releasably close the open end. A needle retainer is mounted within the container proximate to the closed end. A position of the needle retainer relative to the closed end is such that the distance between the needle retainer and the closed end is shorter than the length of a protruding needle of the automatic injector.
A further aspect of the invention relates to a method for using an automatic injector including a cartridge and needle assembly coupled to an actuation assembly including a stored energy source. The method comprises storing the automatic injector in a container in an unused condition. The automatic injector is used, resulting in the extension of a needle. The automatic injector is returned to the container after use, thereby causing the automatic injector to be retained in the container by engagement of the extended needle with retaining structure provided within the container.
Other aspects and advantages of the invention will become apparent from the following description.
The invention will be described with reference to the following drawing figures, in which like numerals represent like structures, and in which:
Typically, the container 10 would be distributed with an automatic injector inside, and would thus serve, at least in part, as product packaging for the automatic injector. Accordingly, the central exterior surface 12 of the container 10 provides space for product labeling, usage directions, or other necessary indicia. Such labeling and indicia may be printed on labels and attached to the exterior surface 12, or they may be formed or printed on the central exterior surface 12 during the manufacture of the container 10.
In general, the container 10 may be made of a conventional plastic material such as polypropylene (PP). However, the container 10, or portions thereof, may also be made of more penetration resistant materials, such as poly(ethylene terephthalate) (PET), as will be explained below in more detail.
The container 10 has a closed needle-receiving end, generally indicated at 14, and an open end 16 opposite the needle-receiving end 14. The opening 24 in the open end 20 is of sufficient size to allow an automatic injector to be removed and replaced. In
The container 10 is designed to house an automatic injector such that its needle-bearing end extends toward the needle-receiving end 14 of the container 10. The needle-receiving end 14 of the container 10 may have a smaller diameter than the rest of the container 10, depending on the diameter of the automatic injector that it is designed to accommodate, so as to encourage users to insert the automatic injector in the proper orientation. As shown in
In particular, although the container 10 is designed to house an automatic injector with the needle-bearing end of the automatic injector facing the needle-receiving end 14 of the container 10, it is possible that the automatic injector may be placed in the container, accidentally or deliberately, such that the needle-bearing end of the automatic injector faces the cap 18. For that reason, the cap 18 is preferably made of a material of sufficient thickness, durability, and penetration resistance such that if the automatic injector were to be accidentally activated with the needle-bearing end facing the cap 18, the protruding needle would not penetrate the cap 18. Alternatively, one wall of the cap 18, such as the top wall, indicated by reference numeral 19 in
The material of which the needle-receiving end 14 is made is at least partially translucent and, in some embodiments, may be fully transparent. In other embodiments, the needle-receiving end 14 may be translucent, partially translucent, or opaque, with particular portions that are fully or partially transparent. The entire container 10 may also be made of a translucent or transparent material. This feature and its utility will be described in more detail below. Regardless of the degree of light permeability of the container 10, the cap 18, or any portions thereof, the container 10 and cap 18 may be capable of blocking or absorbing ultraviolet (UV) light. For example, a UV-absorbing agent could be added to the polymer mix from which the container 10 is formed. Many such UV-absorbing agents are known in the polymer and molding arts. UV blocking or absorbing capability helps to ensure that the medicament within the automatic injector is not compromised by exposure to UV light, even if the container 10 is significantly light permeable.
The bottom 26 of the needle-receiving end 14 has a shock-absorbing eyelet 28. The eyelet 28 takes the form of an arc of material that extends across the bottom 26 of the needle-receiving end 14. The eyelet 28 acts as a shock absorber to absorb at least some of the force if the container 10 is dropped and the bottom 26 of the needle-receiving end 14 impacts another surface. The eyelet 28 would also allow a user to attach a carrying strap, so that the container may be conveniently carried. At the peak of its arc, the eyelet 28 may provide from about 1 mm to about 5 mm of clearance for the attachment of a strap. In other embodiments of the invention, there may be significant clearance between the eyelet 28 and the bottom 26.
In the embodiment shown in
The automatic injector 50 is shown schematically in
The automatic injector 50 also includes an actuation assembly, only portions of which are shown in
However, the difference in length between the container 10 and the automatic injector 50 is most desirably the smallest length difference between the two that will prevent the user from accidentally removing the safety cap 62. That difference may be no more than a few millimeters. In general, the container 10 should be as small as possible, so that it can be conveniently and consistently carried by a user. If the container 10 is too large, the user may not be inclined to carry it, in which case the automatic injector 50 may not be available when it is needed.
When the user needs to use the automatic injector 50, he or she removes the cap 18 from the container 10, removes the automatic injector 50 from the container 10 as was described above, and then uses the automatic injector 50 in accordance with the manufacturer's instructions. Once the automatic injector 50 is used, the user replaces the automatic injector 50 in the container 10, inserting the automatic injector 50 such that the needle 72 is oriented toward the needle-receiving end 14 of the container 10. If the automatic injector 50 is difficult to re-insert, the user may place the cap 18 on the container 10 and turn the cap 18 toward engagement with the container 10. As the user turns the cap 18, the torque applied to the cap 18 will cause an axial force to be exerted on the automatic injector 50, forcing it into the container 10. The cap 18 may thus provide the user with a significant mechanical advantage if used to “seat” the used automatic injector 50 within the container 10 in this manner.
As the needle 72 enters the needle-receiving end 14 of the container 10, the motion of the needle 72 causes a series of movements, which may result in the position shown in
When the cover sleeve 84 is in the downward position, the indicator sleeve 80 is exposed. Because the needle-receiving portion 14 of the container 10 is at least partially translucent, the indicator sleeve 80 can be seen from the outside of the container 10. Accordingly, a user can determine, merely by looking at the outside of the container 10, whether or not the automatic injector 50 inside the container 10 has been used.
One of the advantages of the present invention is its ability to accommodate needles of various sizes. Depending on the type of automatic injector 50 (and the type of injection for which it is designed), the needle 72 of the automatic injector may range in length from about 0.4 inches (approximately 10 millimeters) to 0.975 inches (approximately 24.8 millimeters). If the needle 72 is sufficiently long, the automatic injector 50 will not be fully seated in the container 10 when the needle 72 strikes the bottom of the container 10. In that case, as the user pushes the automatic injector 50 fully into the container 10, the needle 72 bends and becomes crippled, as shown in
Because the bottom 26 of the container 10 and the cover sleeve 84 may be used to cripple the needle, it is advantageous if those components are made of or lined with a tough material that resists penetration, such as PET. Alternatively, a reinforcing plate of either plastic or metal could be fixed to the cover sleeve 84 or the inside bottom 26 of the container 10. Embodiments of the invention that employ a reinforcing component at the bottom of the container will be described below in more detail.
If the user does open the container 10 after the automatic injector 50 has been used, he or she will find it difficult to remove the used automatic injector 50 from the container. This is because the penetrated indicator sleeve 80 acts as a retaining member and exerts a frictional force on the needle 72 that opposes an attempt to remove the automatic injector 50 from the container 10. The indicator sleeve 80, or its bottom portion 81, may be made of a thermoplastic elastomer having a relatively high coefficient of friction so as to produce the greatest possible amount of friction when in engagement with the needle 72. Additionally, if the needle 72 is of a length that causes it to be crippled by striking the bottom 26 of the container 10, the crippled needle 72 itself may make the used automatic injector 50 difficult to remove from the container 10.
Although in the container 10, a cover sleeve 84 is moved by the needle 72 of the automatic injector 50, other embodiments are possible. For example, in another embodiment of the invention that utilizes the same principles as in the container 10, a green indicator flag could be shown through the window 88 until the used automatic injector 50 is inserted into the container 10, at which time the needle 72 of the automatic injector 50 would cause the green indicator flag to be moved to reveal a white or red “used” indicator flag. This could be implemented, for example, by making the cover sleeve 84 green and the underlying indicator sleeve 80 either white or red. Alternatively, a green indicator flag or sleeve could be covered by another movable sleeve. In general, the indicating mechanism and its colors should be chosen so as to give the user a readily identifiable indication of use.
In the container 10, the visibility of the indicator sleeve 80 through the window 88 provides an indication that the automatic injector 50 has been used. However, in other embodiments of the invention, the needle 72 itself may serve as an indicator that the automatic injector 50 has been used.
The container 100 has pointing indicia 115 inscribed on the outer surface of the needle-receiving end 114 to direct the user's attention to the portion of the needle-receiving end 114 where the needle 72 is visible when the automatic injector 50 has been used. In alternative embodiments, the pointing indicia 115 may be painted, marked, integrally formed, or applied as labels to the needle-receiving end 114. If desired, the pointing indicia 115 may also be omitted.
When the automatic injector 50 is returned to the container 100 after use (optionally by using the container cap 18 to exert greater mechanical advantage on the automatic injector 50), the needle 72 penetrates and advances through the needle retainer 180. The needle 72 can then be seen through a transparent window 188 in the needle-receiving portion 114, indicating that the automatic injector has been used. The needle retainer 180 exerts a frictional force on the needle 72 that tends to oppose an attempt to remove it. If the needle 72 is long enough, it may strike the bottom 182 of the needle-receiving portion 114 and become crippled, as shown in
Other embodiments of containers according to the invention may combine the features of the two embodiments described above to provide a colored, highly visible “used” indicator in combination with a simplified container that is designed to retain a used automatic injector. In some embodiments, the indicator function may be provided as a portion of the automatic injector itself.
For example,
The container 200 includes many of the features of the containers 10 and 100 that were described above. Certain features that are not shown in
The automatic injector 202 has an actuation assembly, generally indicated at 250, a chamber, generally indicated at 252, that is made of glass, plastic, or another suitable material and is configured to contain a medicament solution, and a hub and needle assembly, generally indicated at 254. However, instead of a single chamber 252 for medicament, the automatic injector 202 may be of the type designed to carry a two component wet/dry medicament or a two component wet/wet medicament, in which case it would have two chambers separated by an appropriate sealing structure. U.S. Pat. Nos. 6,641,561 and 6,770,052 provide details on the construction of such automatic injectors and their sealing and mixing structures.
The actuation assembly 250 includes a safety cap 256 mounted on the rear end of the automatic injector 202. The safety cap 256 includes a downwardly extending safety pin 258 formed on the inward side of the top surface of the cap 256. In the position shown in
The collet 262 is surrounded by a cylindrical sleeve having an inwardly extending flange at the rearward end thereof. The collet 262 has a forward annular flange 272. A coil spring 274 surrounds the collet 262 and is compressed between the flange of the cylindrical sleeve and the annular flange 272. At its forward end, the collet 262 engages a spacer-indicator member 276.
The spacer-indicator member 276 is a brightly colored component, typically made of red plastic or the equivalent, that includes one end configured to receive and engage the collet 262 and the other end configured to receive and engage a plunger 278 positioned sealingly within the chamber 252 for sliding movement therein. (Alternatively, the spacer-indicator member 276 may engage an insert connected to the plunger 278.) The spacer-indicator member 276 is generally cylindrical in shape, and may be varied in overall length so as to allow the plunger 278 to be initially positioned within the chamber 252 at any desired position. For example, if the medicament dose to be contained in the chamber 252 does not require the entire volume of the chamber 252, the spacer-indicator member 276 may be made with a longer length, so that plunger 278 is initially positioned further along the length of the chamber 252 and the effective volume of the chamber 252 is thus reduced. Therefore, when the volume of the medicament dose is smaller than the volume of the chamber 252, a spacer-indicator member 276 of an appropriate length can reduce the possibility that an air bubble will accumulate in the unused volume of the chamber 252.
To activate the automatic injector 202, the safety cap 256 is manually removed from the automatic injector 202, thus the safety pin 258 is removed from its initial position separating the spring fingers 264. When the forward portion of the housing 280 is pressed against an administration site, the spring fingers 264 are forced upward and, by interaction with the semi-conical surfaces 266, toward one another and off of the retaining surfaces of the flange. The compressed spring 274 is then free to release its stored energy to move the collet 262 forwardly under the force of the spring 274, causing the needle 72 to extend through the forward portion of the housing 280 and the medicament to be injected.
The container 200 has a mechanism for retaining the needle 72 of the automatic injector 202 similar to that of the container 100 illustrated in
Below the needle retainer 208 in the needle-receiving end 204 of the container 200 is a shield 212 which is held in place both by engagement with the inner circumferential shelf 206 and by the fit of the needle retainer 208 above it. The shield 212 is substantially cap-shaped and rests on the bottom of the needle-receiving end 204 of the container with its open end facing upwards. In general, the shield 212 is intended to prevent the needle 72 from penetrating the container 200. Typically, the shield 212 would be made of stainless steel or another metal that is compatible with (i.e., not corroded or otherwise damaged by) the medicament in the automatic injector 202. However, in some embodiments, the shield 212 may be made of PET or another penetration resistant plastic.
If the needle 72 is of sufficient length to strike the shield 212 and become crippled, its final position after contact with the shield 212 may be that shown in
To some extent, the spacing between the needle retainer 208 and the shield 212 adds to the cushioning and shock absorbing effect of the needle retainer 208, because the needle retainer 208 can deflect and rebound to dissipate shock.
In the embodiment of
A flange 304 on the upper portion of the container 200 defines the position to which the user will need to screw the cap 18 in order to ensure that the needle 72 is crippled after it enters the container 200. (Typically, the arrangement of the container 200 and the cap 18 is such that a small vent gap is left between the two when the cap 18 is screwed down fully.)
The container 200 also includes two anti-roll protrusions 306 spaced opposite one another on the lower portion of the outer surface of the container 200. The anti-roll protrusions 306 reduce the likelihood that the container 200 will roll more than about 180° from the position in which it is placed. Although the container 200 does not include an eyelet 28, its bottom surface 308 is rounded, which helps to dissipate shock if the container 200 is dropped on its end.
As was described above, the recessed surface 302 provides a surface over which a clip may be placed to attach multiple containers 200 to one another. Such clips may be used on other containers 10, 100 according to the invention, although the recessed surface 302 substantially prevents a clip from sliding along the length of the container 200.
As is best seen in
The overall “S” shape of the clip 308 will reduce the amount of force needed to remove a container 10, 100, 200 from the clip 308 in an emergency, as compared with a more conventional double C-clip. Additionally, texture 314 on the outer surface of the clip 308 makes the clip 308 easier to grip and may encourage users to replace the container 10, 100, 200 in the clip 308 once the automatic injector 50, 202 has been used. It is contemplated that the clip 308 may include a suitable attachment assembly for carrying the clip on a belt or securing to an article of clothing or desired surface or article.
Although the invention has been described with respect to certain embodiments, the described embodiments are intended to be exemplary, rather than limiting. Modifications and variations to those embodiments are possible within the scope of the appended claims.
This application relates to and claims priority to U.S. Provisional Patent Application No. 60/516,733, filed on Nov. 4, 2003 and U.S. Provisional Patent Application No. 60/517,910, filed on Nov. 7, 2003. The disclosures of each are incorporated specifically herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
1506429 | Kahn et al. | Aug 1924 | A |
1711594 | Gillespie | May 1929 | A |
1718701 | O'Sullivan | Jun 1929 | A |
1838825 | Goldstein | Dec 1931 | A |
2400722 | Swan | May 1946 | A |
3363497 | Thompson | Jan 1968 | A |
3367486 | Larson et al. | Feb 1968 | A |
4188950 | Wardlaw | Feb 1980 | A |
4332323 | Reenstierna | Jun 1982 | A |
4634428 | Cuu | Jan 1987 | A |
4716710 | Galy et al. | Jan 1988 | A |
4728320 | Chen | Mar 1988 | A |
4728321 | Chen | Mar 1988 | A |
4735311 | Lowe et al. | Apr 1988 | A |
4872552 | Unger | Oct 1989 | A |
4877132 | Makris et al. | Oct 1989 | A |
5002533 | Jullien | Mar 1991 | A |
5015234 | Jullien | May 1991 | A |
5074848 | Burt et al. | Dec 1991 | A |
5080651 | Jullien | Jan 1992 | A |
5084027 | Bernard | Jan 1992 | A |
5104375 | Wolf et al. | Apr 1992 | A |
5137516 | Rand et al. | Aug 1992 | A |
5156267 | Yates, Jr. et al. | Oct 1992 | A |
5161681 | Kemp et al. | Nov 1992 | A |
5172808 | Bruno | Dec 1992 | A |
5188600 | Jullien | Feb 1993 | A |
5232454 | Hollister | Aug 1993 | A |
5232455 | Hollister | Aug 1993 | A |
5358489 | Wyrick | Oct 1994 | A |
5391151 | Wilmot | Feb 1995 | A |
5417326 | Winer | May 1995 | A |
5519931 | Reich | May 1996 | A |
5522503 | Halbich | Jun 1996 | A |
5566828 | Claes et al. | Oct 1996 | A |
5695472 | Wyrick | Dec 1997 | A |
5918443 | Phillips | Jul 1999 | A |
5941854 | Bhitiyakul | Aug 1999 | A |
5950827 | Odom et al. | Sep 1999 | A |
5980495 | Heinz et al. | Nov 1999 | A |
6001082 | Dair et al. | Dec 1999 | A |
6026959 | Lowe | Feb 2000 | A |
6102893 | Aneas | Aug 2000 | A |
6155420 | Phillips | Dec 2000 | A |
6183439 | Nakajima | Feb 2001 | B1 |
6210369 | Wilmot et al. | Apr 2001 | B1 |
6217558 | Zadini et al. | Apr 2001 | B1 |
6241709 | Bechtold et al. | Jun 2001 | B1 |
6405912 | Giannou | Jun 2002 | B2 |
6454746 | Bydlon et al. | Sep 2002 | B1 |
6576918 | Fu et al. | Jun 2003 | B1 |
6595362 | Penney et al. | Jul 2003 | B2 |
6641560 | Bechtold et al. | Nov 2003 | B1 |
6641561 | Hill et al. | Nov 2003 | B1 |
6702785 | Collins | Mar 2004 | B1 |
6767336 | Kaplan | Jul 2004 | B1 |
6793646 | Giambattista et al. | Sep 2004 | B1 |
20010054631 | Giannou | Dec 2001 | A1 |
20020049407 | Hill et al. | Apr 2002 | A1 |
20020050462 | Penney et al. | May 2002 | A1 |
20030132128 | Mazur | Jul 2003 | A1 |
20040069667 | Tomellini et al. | Apr 2004 | A1 |
20040236289 | Ferguson et al. | Nov 2004 | A1 |
Number | Date | Country |
---|---|---|
19959507 | Jun 2000 | DE |
0 634 140 | Jan 1995 | EP |
WO 9855168 | Dec 1998 | WO |
WO 9937343 | Jul 1999 | WO |
WO 0178806 | Oct 2001 | WO |
Number | Date | Country | |
---|---|---|---|
20050148933 A1 | Jul 2005 | US |
Number | Date | Country | |
---|---|---|---|
60516733 | Nov 2003 | US | |
60517910 | Nov 2003 | US |